PHARMCO, a Sterile Compounding Pharmacy
PHARMCO will help meet a critical need for safe FDA-approved, commercially-available sterile compounding drugs in the United States.
PHARMCO was formed to alleviate the severe shortage of sterile compounding admixtures in the U.S. and introduce a higher benchmark for safety and quality. The company provides admixing of commercially-available FDA-approved drugs. It strives to exceed cGMP and USP 797 standards. The initial target market includes hospitals, surgical centers, and other healthcare providers in Missouri and Illinois with a goal to expand nationally.